AstraZeneca picks Catalent for packaging, supplying potential COVID-19 vaccine

British drugmaker AstraZeneca Plc has struck a deal with contract manufacturer Catalent Inc to help meet its global target of supplying two billion doses of its potential COVID-19 vaccine.